Adverse events29

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 29

Type	Event	Organ system	Group	Affected	At risk	Events
other	Constipation	Gastrointestinal disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	34	53	34
other	Nausea	Gastrointestinal disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	33	53	33
other	Fatigue	General disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	32	53	32
other	Anemia	Blood and lymphatic system disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	27	53	27
other	Neutrophil count decreased	Blood and lymphatic system disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	22	53	22
other	Platelet count decreased	Blood and lymphatic system disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	19	53	19
other	Diarrhea	Gastrointestinal disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	18	53	18
other	Vomiting	Gastrointestinal disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	17	53	17
other	White blood cell count decreased	Blood and lymphatic system disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	14	53	14
other	Decreased appetite	Metabolism and nutrition disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	13	53	13
other	Oedema peripheral	General disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	12	53	12
other	Dyspnea	Respiratory, thoracic and mediastinal disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	11	53	11
other	Headache	Nervous system disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	11	53	11
other	Hypertension	Vascular disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	11	53	11
other	Pyrexia	General disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	11	53	11
other	Abdominal pain	Gastrointestinal disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	14	53	14
serious	Gastrointestinal disorders	Gastrointestinal disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	8	53	8
serious	Infections and infestations	Infections and infestations	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	5	53	5
serious	Hepatobiliary disorders	Hepatobiliary disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	3	53	3
serious	Nervous system disorders	Nervous system disorders	Xermelo 250mg Plus 1L Therapy for a Week, Then Xermelo 500mg	3	53	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03790111/events

API reference For AI assistants

Adverse events29

Sources 3

Read this list from software.